Bioventix (LON:BVXP) Sets New 1-Year Low – Time to Sell?

Bioventix PLC (LON:BVXP)’s share price reached a new 52-week low on Monday . The company traded as low as GBX 1,600 and last traded at GBX 1,628, with a volume of 11238 shares changing hands. The stock had previously closed at GBX 1,699.

Bioventix Stock Down 4.2%

The firm has a 50-day simple moving average of GBX 1,786.43 and a 200-day simple moving average of GBX 2,097.06. The stock has a market cap of £85.06 million, a PE ratio of 11.36 and a beta of 0.35.

Insider Transactions at Bioventix

In related news, insider Bruce Hiscock bought 150 shares of the business’s stock in a transaction on Tuesday, November 25th. The stock was acquired at an average price of GBX 2,071 per share, for a total transaction of £3,106.50. Company insiders own 6.16% of the company’s stock.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.